Seminars in Hematology
Volume 45, Supplement 1 , Pages S21-S24, April 2008

Factor VIIa Interaction With Tissue Factor and Endothelial Cell Protein C Receptor on Cell Surfaces

  • Usha R. Pendurthi

      Affiliations

    • Corresponding Author InformationAddress correspondence to Usha R. Pendurthi, PhD, Biomedical Research, The University of Texas Health Center at Tyler, 11937 US Highway 271, Tyler, TX 75708.
  • ,
  • L. Vijaya Mohan Rao

Biomedical Research, The University of Texas Health Center at Tyler, Tyler, TX.

Factor VIIa (FVIIa) is the enzyme that triggers activation of the clotting cascade that eventually leads to fibrin deposition and platelet activation. Association of FVIIa with its cellular receptor, tissue factor (TF), which greatly increases FVIIa enzymatic activity, is essential for the effective initiation of the coagulation pathway. FVIIa also complexes with endothelial cell protein C receptor (EPCR), but this association does not increase the enzymatic activity of FVIIa. This article reviews current knowledge of FVIIa interaction with TF and EPCR on cell surfaces with a specific focus on how these interactions may contribute to FVIIa and TF clearance, thereby regulating TF–FVIIa activity.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 STATEMENT OF CONFLICT OF INTEREST: L. Vijaya Mohan Rao has received a research grant from Novo Nordisk. However, the authors' findings described in this article are supported by grants from the National Institutes of Health (HL58869 and HL65550).

PII: S0037-1963(08)00054-1

doi:10.1053/j.seminhematol.2008.03.014

Seminars in Hematology
Volume 45, Supplement 1 , Pages S21-S24, April 2008